ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
NovaBay Pharmaceuticals Inc New

NovaBay Pharmaceuticals Inc New (NBY)

0,6301
-0,0114
(-1,78%)
Geschlossen 17 März 9:00PM
0,6406
0,0105
(1,67%)
Nach Börsenschluss: 11:47PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,6406
Gebot
-
Fragen
-
Volumen
38.100
0,6251 Tagesbereich 0,656
0,3611 52-Wochen-Bereich 9,079
Marktkapitalisierung
Handelsende
0,6415
Handelsbeginn
0,648
Letzte Trade
100
@
0.6301
Letzter Handelszeitpunkt
Finanzvolumen
US$ 24.580
VWAP
0,645144
Durchschnittliches Volumen (3 Mio.)
244.450
Ausgegebene Aktien
4.885.693
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,18
Gewinn pro Aktie (EPS)
-3,42
Erlöse
14,73M
Nettogewinn
-16,7M

Über NovaBay Pharmaceuticals Inc New

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the Amerikanische Börse with ticker NBY. The last closing price for NovaBay Pharmaceuticals was US$0,64. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of US$ 0,3611 to US$ 9,079.

NovaBay Pharmaceuticals currently has 4.885.693 shares in issue. The market capitalisation of NovaBay Pharmaceuticals is US$3,13 million. NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.18.

NBY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.080614.39285714290.560.6480.55425420.59819882CS
4-0.0104-1.59754224270.6510.70720.55690580.62449328CS
120.12424.00309717380.51660.8350.492444500.66802741CS
260.140828.17126850740.49981.00990.4703115750510.72312874CS
52-4.6094-87.79809523815.259.0790.361131838343.66420275CS
156-342.3594-99.8132361516343442.2250.3611167811033.47877087CS
260-303.7719-99.789561861304.41252670.50.36112112201661.57367258CS

NBY - Frequently Asked Questions (FAQ)

What is the current NovaBay Pharmaceuticals share price?
The current share price of NovaBay Pharmaceuticals is US$ 0,6406
How many NovaBay Pharmaceuticals shares are in issue?
NovaBay Pharmaceuticals has 4.885.693 shares in issue
What is the market cap of NovaBay Pharmaceuticals?
The market capitalisation of NovaBay Pharmaceuticals is USD 3,13M
What is the 1 year trading range for NovaBay Pharmaceuticals share price?
NovaBay Pharmaceuticals has traded in the range of US$ 0,3611 to US$ 9,079 during the past year
What is the PE ratio of NovaBay Pharmaceuticals?
The price to earnings ratio of NovaBay Pharmaceuticals is -0,18
What is the cash to sales ratio of NovaBay Pharmaceuticals?
The cash to sales ratio of NovaBay Pharmaceuticals is 0,21
What is the reporting currency for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals reports financial results in USD
What is the latest annual turnover for NovaBay Pharmaceuticals?
The latest annual turnover of NovaBay Pharmaceuticals is USD 14,73M
What is the latest annual profit for NovaBay Pharmaceuticals?
The latest annual profit of NovaBay Pharmaceuticals is USD -16,7M
What is the registered address of NovaBay Pharmaceuticals?
The registered address for NovaBay Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the NovaBay Pharmaceuticals website address?
The website address for NovaBay Pharmaceuticals is www.novabay.com
Which industry sector does NovaBay Pharmaceuticals operate in?
NovaBay Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 6,09
(25,05%)
97,42M
PMNTPerfect Moment Ltd
US$ 1,13
(22,51%)
180,23k
DXFEason Technology Limited
US$ 7,60
(21,41%)
68,2k
EONREON Resources Inc
US$ 0,4419
(20,41%)
1,22M
AMBOAmbow Education Holding Ltd
US$ 3,08
(18,01%)
22,55k
SBEVSplash Beverage Group Inc
US$ 0,07
(-42,67%)
1,88M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 14,65
(-25,75%)
33,33M
UVIX2x Long VIX Futures ETF
US$ 38,1999
(-17,57%)
5M
MCRPMicropolis Holding Company
US$ 3,53
(-16,80%)
2,24M
UVXYProShares Ultra VIX Short Term Futures ETF
US$ 23,7428
(-12,49%)
16,08M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 19,80
(9,45%)
99,72M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 6,09
(25,05%)
97,42M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 7,131
(-6,17%)
81,11M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 4,96
(-7,46%)
70,87M
GOVTiShares US Treasury Bond ETF
US$ 22,82
(-0,26%)
65,04M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock